• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与顺铂相比,不同波长低强度激光疗法对前列腺癌细胞系的生物活性评估

Evaluation of Biological Activity of Different Wavelengths of Low-Level Laser Therapy on the Cancer Prostate Cell Line Compared With Cisplatin.

作者信息

Zafari Jaber, Abbasinia Hossein, Gharehyazi Hediyeh, Javani Jouni Fatemeh, Jamali Saeed, Razzaghi Mohammadreza

机构信息

Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Cellular and Molecular Biology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

出版信息

J Lasers Med Sci. 2021 May 1;12:e17. doi: 10.34172/jlms.2021.17. eCollection 2021.

DOI:10.34172/jlms.2021.17
PMID:34733740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558701/
Abstract

Cancer is one of the most important problems in the world. Low-level laser therapy (LLLT) has been emerged as a new approach, having both stimulation and inhibition effects on cellular function. The goal of this study was to analyze and compare the different concentrations of cisplatin and wavelengths of laser therapy on the LnCap cell lines. LnCap cells were cultured and treated with different concentrations of cisplatin (0.1, 0.4, 0.8, 1.2 and 2 µg/mL for 24 hours) and wavelengths of laser therapy (610, 630 and 810 nm) (0.45 J/cm) separately. The viability of cells was examined by MTT assay and IC50 was also calculated. Furthermore, a combination of cisplatin IC50 (24 hours) and different wavelengths of the laser was examined. The results of this study showed that 2 µg/mL of cisplatin has the most significant reduction effect on the cell viability of the LnCap cell line. Cisplatin decreased the viability of cells in a dose-dependent manner. Moreover, IC50 of cisplatin was 1.24 µg/mL. On the other hand, LLLT with wavelengths of 610, 630 and 810 nm did not show notable biological effects on cell viability. As known, cisplatin has the capability to reduce the viability of LnCap cell lines. However, LLLT cannot be a remarkable option for the treatment of prostate cancer. Therefore, although laser therapy showed praiseful therapeutic activity against some cancer cell lines, in this study the results indicated that defined laser wavelengths had no inhibitory effects against the prostate cancer cell line.

摘要

癌症是世界上最重要的问题之一。低强度激光疗法(LLLT)已成为一种新方法,对细胞功能具有刺激和抑制作用。本研究的目的是分析和比较不同浓度顺铂和不同波长激光疗法对LnCap细胞系的影响。将LnCap细胞培养后分别用不同浓度的顺铂(0.1、0.4、0.8、1.2和2µg/mL,处理24小时)和不同波长的激光疗法(610、630和810nm,能量密度为0.45J/cm²)进行处理。通过MTT法检测细胞活力并计算IC50。此外,还检测了顺铂IC50(24小时)与不同波长激光的联合作用。本研究结果表明,2µg/mL的顺铂对LnCap细胞系的细胞活力具有最显著的降低作用。顺铂以剂量依赖性方式降低细胞活力。此外,顺铂的IC50为1.24µg/mL。另一方面,波长为610、630和810nm的低强度激光疗法对细胞活力未显示出显著的生物学效应。众所周知,顺铂有降低LnCap细胞系活力的能力。然而,低强度激光疗法并非治疗前列腺癌的显著选择。因此,尽管激光疗法对某些癌细胞系显示出令人称赞的治疗活性,但在本研究中结果表明特定的激光波长对前列腺癌细胞系没有抑制作用。

相似文献

1
Evaluation of Biological Activity of Different Wavelengths of Low-Level Laser Therapy on the Cancer Prostate Cell Line Compared With Cisplatin.与顺铂相比,不同波长低强度激光疗法对前列腺癌细胞系的生物活性评估
J Lasers Med Sci. 2021 May 1;12:e17. doi: 10.34172/jlms.2021.17. eCollection 2021.
2
The effect of cisplatin-low-level laser therapy on cell viability and death of LNCaP prostate cancer cell line.顺铂-低水平激光治疗对 LNCaP 前列腺癌细胞系细胞活力和死亡的影响。
Lasers Med Sci. 2022 Mar;37(2):1283-1288. doi: 10.1007/s10103-021-03386-y. Epub 2021 Aug 10.
3
Effect of Low-Level Laser Therapy and Sinensetin (Combination therapy) on Tumor Cells (Hela) and Normal Cells (CHO).低强度激光疗法与橙皮素(联合疗法)对肿瘤细胞(Hela)和正常细胞(CHO)的影响。
J Lasers Med Sci. 2021 Dec 27;12:e85. doi: 10.34172/jlms.2021.85. eCollection 2021.
4
The enhancing effect of a laser photochemotherapy with cisplatin or zolendronic acid in primary human osteoblasts and osteosarcoma cells in vitro.顺铂或唑来膦酸激光光化学疗法对原代人成骨细胞和骨肉瘤细胞的体外增强作用。
J Oral Pathol Med. 2016 Nov;45(10):803-809. doi: 10.1111/jop.12442. Epub 2016 Apr 28.
5
Investigation of effects of quercetin and low-level laser therapy in cisplatin-induced in vitro peripheral neuropathy model.研究槲皮素和低水平激光疗法对顺铂诱导的体外周围神经病变模型的影响。
Lasers Med Sci. 2023 Jan 23;38(1):49. doi: 10.1007/s10103-023-03718-0.
6
Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.唑来膦酸和顺铂对原代人成纤维细胞和头颈部鳞状细胞癌细胞系UM-SCC-3的激光增强细胞毒性。
J Craniomaxillofac Surg. 2014 Oct;42(7):1469-74. doi: 10.1016/j.jcms.2014.04.014. Epub 2014 May 10.
7
Knockdown of CFTR enhances sensitivity of prostate cancer cells to cisplatin via inhibition of autophagy.敲低 CFTR 通过抑制自噬增强前列腺癌细胞对顺铂的敏感性。
Neoplasma. 2017;64(5):709-717. doi: 10.4149/neo_2017_508.
8
Combined effects of low-level laser therapy and human bone marrow mesenchymal stem cell conditioned medium on viability of human dermal fibroblasts cultured in a high-glucose medium.低强度激光疗法与人类骨髓间充质干细胞条件培养基对在高糖培养基中培养的人类皮肤成纤维细胞活力的联合作用。
Lasers Med Sci. 2016 May;31(4):749-57. doi: 10.1007/s10103-016-1867-1. Epub 2016 Mar 16.
9
Effects of pre-irradiation of low-level laser therapy with different doses and wavelengths in skeletal muscle performance, fatigue, and skeletal muscle damage induced by tetanic contractions in rats.不同剂量和波长的低强度激光疗法预照射对大鼠骨骼肌性能、疲劳及强直收缩诱导的骨骼肌损伤的影响。
Lasers Med Sci. 2014 Sep;29(5):1617-26. doi: 10.1007/s10103-014-1560-1. Epub 2014 Mar 21.
10
Low-Level Laser Irradiation Modulated Viability of Normal and Tumor Human Lymphocytes In Vitro.低强度激光照射对人正常及肿瘤淋巴细胞体外活力的调节作用
J Lasers Med Sci. 2020 Spring;11(2):174-180. doi: 10.34172/jlms.2020.29. Epub 2020 Mar 15.

引用本文的文献

1
The Effect of Photobiomodulation on the Conditioned Media of 3T3-L1 Cells in the Treatment of Breast Cancer.光生物调节对3T3-L1细胞条件培养基在乳腺癌治疗中的作用。
J Lasers Med Sci. 2024 Jul 9;15:e22. doi: 10.34172/jlms.2024.22. eCollection 2024.
2
and its Combination with Cisplatin: A Potential Anticancer Candidate by Modulating Apoptotic Genes.并与顺铂联合应用:通过调节凋亡基因成为一种有潜力的抗癌候选药物。
Anticancer Agents Med Chem. 2024;24(16):1233-1240. doi: 10.2174/0118715206296649240625072637.

本文引用的文献

1
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
2
Photodynamic therapy for cancer: Role of natural products.光动力疗法治疗癌症:天然产物的作用。
Photodiagnosis Photodyn Ther. 2019 Jun;26:395-404. doi: 10.1016/j.pdpdt.2019.04.033. Epub 2019 May 4.
3
Cisplatin: The first metal based anticancer drug.顺铂:第一种金属类抗癌药物。
Bioorg Chem. 2019 Jul;88:102925. doi: 10.1016/j.bioorg.2019.102925. Epub 2019 Apr 11.
4
Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.低强度激光疗法(光生物调节疗法)治疗乳腺癌相关淋巴水肿:一项系统综述
BMC Cancer. 2017 Dec 7;17(1):833. doi: 10.1186/s12885-017-3852-x.
5
The use of lasers in the treatment of skin cancer: A review.激光在皮肤癌治疗中的应用:综述
J Cosmet Laser Ther. 2017 Dec;19(8):451-458. doi: 10.1080/14764172.2017.1349321. Epub 2017 Jul 10.
6
The Diagnosis and Treatment of Prostate Cancer: A Review.前列腺癌的诊断与治疗:综述
JAMA. 2017 Jun 27;317(24):2532-2542. doi: 10.1001/jama.2017.7248.
7
Low-level laser therapy in the treatment of recurrent aphthous ulcers: a systematic review.低强度激光疗法治疗复发性阿弗他溃疡:一项系统评价
ScientificWorldJournal. 2015;2015:150412. doi: 10.1155/2015/150412. Epub 2015 Mar 23.
8
Biological effects of low level laser therapy.低强度激光疗法的生物学效应
J Lasers Med Sci. 2014 Spring;5(2):58-62.
9
Synergistic effect of photodynamic therapy and cisplatin: a novel approach for cervical cancer.光动力疗法与顺铂的协同效应:一种宫颈癌治疗新方法
J Photochem Photobiol B. 2014 Nov;140:365-73. doi: 10.1016/j.jphotobiol.2014.08.021. Epub 2014 Sep 7.
10
A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model?肾毒性、肝毒性或睾丸毒性的组织病理学研究:在动物模型中,顺铂诱导的毒性副作用的首次观察结果是哪一种?
J Nephropathol. 2012 Oct;1(3):190-3. doi: 10.5812/nephropathol.8122. Epub 2012 Oct 1.